Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deuschle

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 12, 2018
Epigenetics-by-sex interaction for somatization conferred by methylation at the promoter region of SLC6A4 geneH Palma-Gudiel, V Peralta, M Deuschle, et al.
Psychoneuroendocrinology|May 20, 2000
Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactoneI Heuser, M Deuschle, B Weber, et al.
Neurobiology of Aging|May 1, 1997
Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variationA Hartmann, J D Veldhuis, M Deuschle, et al.
Epigenetics|September 2, 2015
Maternal psychosocial stress during pregnancy alters the epigenetic signature of the glucocorticoid receptor gene promoter in their offspring: a meta-analysisH Palma-Gudiel, A Córdova-Palomera, E Eixarch, et al.
Journal of Psychopharmacology (Oxford, England)|June 28, 2008
Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trialS Englisch, U Knopf, B Scharnholz, et al.
Neuroendocrinology|November 21, 1998
Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humansM Deuschle, B Weber, M Colla, et al.
Neuropsychobiology|February 15, 2001
The glutamate antagonist riluzole and its effects upon basal and stress-induced activity of the human hypothalamus-pituitary-adrenocortical system in elderly subjectsA Kniest, C Wiesenberg, B Weber, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patientsI Heuser, M Deuschle, P Luppa, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Increased diurnal plasma concentrations of cortisone in depressed patientsB Weber, S Lewicka, M Deuschle, et al.
Der Nervenarzt|January 17, 2015
[Cardiac and metabolic risk factors in severe mental disorders. Task of a prevention manager]F Lederbogen, P Schwarz, S Häfner, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 12, 2018
Epigenetics-by-sex interaction for somatization conferred by methylation at the promoter region of SLC6A4 geneH Palma-Gudiel, V Peralta, M Deuschle, et al.
Psychoneuroendocrinology|May 20, 2000
Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactoneI Heuser, M Deuschle, B Weber, et al.
Neurobiology of Aging|May 1, 1997
Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variationA Hartmann, J D Veldhuis, M Deuschle, et al.
Epigenetics|September 2, 2015
Maternal psychosocial stress during pregnancy alters the epigenetic signature of the glucocorticoid receptor gene promoter in their offspring: a meta-analysisH Palma-Gudiel, A Córdova-Palomera, E Eixarch, et al.
Journal of Psychopharmacology (Oxford, England)|June 28, 2008
Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trialS Englisch, U Knopf, B Scharnholz, et al.
Neuroendocrinology|November 21, 1998
Mineralocorticoid receptor also modulates basal activity of hypothalamus-pituitary-adrenocortical system in humansM Deuschle, B Weber, M Colla, et al.
Neuropsychobiology|February 15, 2001
The glutamate antagonist riluzole and its effects upon basal and stress-induced activity of the human hypothalamus-pituitary-adrenocortical system in elderly subjectsA Kniest, C Wiesenberg, B Weber, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patientsI Heuser, M Deuschle, P Luppa, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Increased diurnal plasma concentrations of cortisone in depressed patientsB Weber, S Lewicka, M Deuschle, et al.
Der Nervenarzt|January 17, 2015
[Cardiac and metabolic risk factors in severe mental disorders. Task of a prevention manager]F Lederbogen, P Schwarz, S Häfner, et al.
Pageof 9